Healthcare Industry News: Eagle Eye Platinum
News Release - March 4, 2011
Volcano Announces the Introduction of the Eagle Eye(R) Platinum Digital IVUS Catheter at the 20th PCI Live Demonstration Course in KurashikiNow cleared for sale in Japan, the Eagle EyeŽ Platinum catheter offers significant improvements of special interest to the Japanese market
SAN DIEGO, March 4, 2011 -- (Healthcare Sales & Marketing Network) -- Volcano Corporation (Nasdaq:VOLC ), a leading developer and manufacturer of precision guided therapy tools designed to enhance the diagnosis and treatment of coronary and peripheral vascular disease, announced today that it received clearance to market the Eagle EyeŽ Platinum digital IVUS catheter in Japan, and will introduce the device at the 20th PCI Live Demonstration Course in Kurashiki, which starts on March 3rd. This state-of-the-art catheter offers all of the benefits of the predecessor Eagle EyeŽ Gold catheter, plus improved deliverability and the convenience of additional radiopaque markers. Full market release of Eagle EyeŽ Platinum in Japan is expected in the second quarter of 2011.
"Volcano is thrilled to offer our most advanced digital IVUS catheter to the largest and most developed IVUS market in the world," commented David Sheehan, President of the IVUS and FM Business Units at Volcano Corporation. "Since the catheter's release in the US and Europe, customers have been impressed with its deliverability through tortuous anatomy and complex lesions, and have appreciated the ability to more accurately perform angiographic lesion length assessments by using the integrated radiopaque markers instead of taking the time to use a separate pullback device. We are expecting the strong interest that Japanese physicians have shown for the Eagle EyeŽ Platinum catheter to carry over into their clinical experience as well."
"In Japan, physicians are tackling increasingly complex and challenging PCI," added Junichi Osawa, President and Managing Director of Volcano Japan. "The more tapered tip design of the Eagle Eye Platinum catheter, with lower entry profile and new GlyDxŽ hydrophilic coating, facilitates guidance of CTO procedures, and the smoother lower profile catheter transitions improve delivery through smaller guides. This can help facilitate radial access, an approach common in Japan and growing elsewhere in the world due to reduced bleeding complications."
About Eagle EyeŽ Platinum
The Eagle EyeŽ Platinum is the third generation of catheters in the Eagle EyeŽ product line. Eagle EyeŽ catheters have been used in over 500,000 procedures worldwide. Like Eagle EyeŽ Gold, the Eagle EyeŽ Platinum catheter offers fast, plug-and-play functionality as well as grayscale IVUS, VHŽ IVUS, and ChromaFloŽ imaging modalities.
About Volcano Corporation
Volcano Corporation (NASDAQ:VOLC ) is revolutionizing the medical device industry with a broad suite of technologies that make imaging and therapy simpler, more informative and less invasive. Our products empower physicians around the world with a new generation of analytical tools that deliver more meaningful information, using sound and light as the guiding elements. Founded in cardiovascular care and expanding into other specialties, Volcano is changing the assumption about what is possible in improving patient outcomes by combining imaging and therapy together. For more information, visit the company's website at www.volcanocorp.com.
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release that are not historical facts may be considered "forward-looking statements." Forward-looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties which may cause Volcano's results to differ materially and adversely from the statements contained herein. Some of the potential risks and uncertainties that could cause actual results to differ from those predicted include competition, the pace and extent of market adoption of the Eagle EyeŽ Platinum in Japan, unexpected new data, safety and technical issues,, and market conditions. These and additional risks and uncertainties are more fully described in Volcano's filings made with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements which speak only as of the date they are made. Volcano disclaims any obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.